Category Archive: Finance, No picture
These 3 Companies Generate Serious Cash
Image Source: UnsplashStrong cash flows reflect financial stability, allowing companies to pay down debt, pursue growth opportunities, and shell out dividend payments.These companies are also better equipped to weather an economic downturn, providing another beneficial advantage for investors from a long-term standpoint.And for those interested in investing in strong cash flows, three companies – Apple (AAPL – Free […]
Elliott Wave Technical Analysis: ADA Cardano Crypto Price News For Friday, Jan 17
Image Source: UnsplashElliott Wave Analysis TradingLounge Daily ChartADA/ U.S. dollar(ADAUSD)ADAUSD Elliott Wave Technical AnalysisFunction: Counter TrendMode: CorrectiveStructure: Flatposition: Wave BDirection Next higher Degrees:Wave Cancel invalid level:Details: Short-term: Price will continue to rise in Wave B with target at 1.320.ADA/ U.S. dollar(ADAUSD)Trading Strategy:The price will continue to adjust up in Wave B with the target at 1.320. After Wave B […]
Asia Week Ahead: BoJ Decision And GDP From Korea And Taiwan
Image Source: UnsplashThe market will pay attention to the Bank of Japan’s rate action as the latest comments from the BoJ officials are leaning towards being hawkish. Meanwhile, Taiwan is expected to log a solid growth rate while South Korea’s GDP will show how the recent political turmoil dampened the economy. Japan: BoJ rate decision is a […]
Stocks Fail To Push Through Key Levels Of Resistance As Rates Look For Support
Image Source: UnsplashStocks finished lower on the day, with the S&P 500 dropping by 21 bps and the Nasdaq 100 falling by about 70 bps. Still, the markets were more settled now that the S&P 500 moved back into positive gamma, causing volatility to subside.The S&P 500 closed just below the 50-day moving average, which has […]
Markets Stall At 20-Day MAs
Image Source: UnsplashAfter yesterday’s big gains it was always going to be hard for markets to continue in the same vein. All markets are near 20-day MAs, with the Russell 2000 (IWM) just above this key moving average and the S&P and Nasdaq just below. Volume was down on yesterday, so no distribution or accumulation to […]
Trump to make crypto a key national priority
Key Takeaways Donald Trump plans to prioritize crypto as a key policy area through an executive order. The move signals a shift from Biden’s administration’s regulatory approach towards a more supportive stance on crypto. Share this article President-elect Donald Trump plans to issue an executive order prioritizing crypto as a key policy area, according to […]
AMD Faces Analyst Downgrades: Could The MI350 Chip Series Boost Stock Performance?
Image Source: Unsplash Advanced Micro Devices (AMD) received another downgrade on Thursday, days after Goldman Sachs and HSBC downgraded the stock. Wolfe Research analyst Chris Caso downgraded AMD from Buy to Peer Perform on Thursday. Caso also trimmed his rating on AMD shares and removed his $210 price target. Shares of semiconductor manufacturers such as Nvidia, Marvell Technology, and Applied […]
Autonomous Worlds enter the DeFAI era with AI agent-driven ecosystems
Key Takeaways Autonomous Worlds, powered by the Autonomous World Engine (AWE), merges AI and DeFi to build self-sustaining digital ecosystems. AI agent tokens are projected to reach a $60 billion market cap by 2025 as they transform various crypto-related functions. Share this article Autonomous Worlds is emerging as a new project in the DeFAI space, […]
Here’s How To Play The “Big Bounce”
Image Source: Unsplash Some weeks, you see it all… and this is one of those weeks.What had been a tape on life support roared back – violently – the second traders perceived inflation was cooling off. (Whether that perception is accurate… well, that’s a different story.)Bonds have staged a recovery, as well, which means savvy folks […]
Will GSK’s Seasonal Strength And Oncology Focus Drive Gains?
Image Source: Unsplash Is GSK Entering a Seasonal Sweet Spot? GSK has recently garnered attention due to GSK agreeing to buy US Cancer Biotech firm IDRx. GSK Plc will acquire US biotech IDRx for up to $1.15 billion, with $1 billion upfront and $150 million tied to milestones. IDRx’s experimental drug targets gastrointestinal stromal tumors, potentially […]
